Technical Analysis for ATRA - Atara Biotherapeutics, Inc.

Grade Last Price % Change Price Change
F 0.60 -4.06% -0.03
ATRA closed down 4.06 percent on Monday, March 18, 2024, on 39 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
NR7 Range Contraction -4.06%
Narrow Range Bar Range Contraction -4.06%

   Recent Intraday Alerts

Alert Time
Down 3% about 12 hours ago
Fell Below Previous Day's Low about 12 hours ago
Down 2 % about 12 hours ago
Down 1% about 12 hours ago
Rose Above Lower Bollinger Band about 13 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Atara Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of muscle wasting conditions and oncology. Its lead product candidate is PINTA 745, which is in a Phase II clinical trial for the treatment of protein-energy wasting in end-stage renal disease patients. The company is also developing STM 434, a targeted therapy for ovarian cancer and other solid tumors; and a pipeline of product candidates that are in preclinical development. Atara Biotherapeutics, Inc. was founded in 2012 and is headquartered in Brisbane, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Solid Tumors Drugs Clinical Development Ovarian Cancer Targeted Therapy End Stage Renal Disease Renal Disease Stage Renal Disease

Is ATRA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 3.17
52 Week Low 0.1986
Average Volume 3,500,991
200-Day Moving Average 1.23
50-Day Moving Average 0.73
20-Day Moving Average 0.73
10-Day Moving Average 0.68
Average True Range 0.09
RSI (14) 37.11
ADX 25.86
+DI 22.40
-DI 19.23
Chandelier Exit (Long, 3 ATRs) 0.68
Chandelier Exit (Short, 3 ATRs) 0.85
Upper Bollinger Bands 0.85
Lower Bollinger Band 0.60
Percent B (%b) -0.02
BandWidth 34.65
MACD Line -0.03
MACD Signal Line -0.02
MACD Histogram -0.0177
Fundamentals Value
Market Cap 60.7 Million
Num Shares 102 Million
EPS -2.78
Price-to-Earnings (P/E) Ratio -0.21
Price-to-Sales 18.35
Price-to-Book 1.97
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.66
Resistance 3 (R3) 0.67 0.65 0.65
Resistance 2 (R2) 0.65 0.63 0.65 0.65
Resistance 1 (R1) 0.62 0.62 0.62 0.62 0.64
Pivot Point 0.61 0.61 0.60 0.60 0.61
Support 1 (S1) 0.58 0.59 0.57 0.57 0.55
Support 2 (S2) 0.56 0.58 0.56 0.54
Support 3 (S3) 0.53 0.56 0.54
Support 4 (S4) 0.53